IL-5 R alpha

IL-5 R alpha 분자 정보

영어 이름Interleukin-5 receptor subunit alpha시판 약물 수1
임상 약물 수2표적 별명Interleukin 5 Receptor, Alpha,Interleukin-5 Receptor Subunit Alpha,HSIL5R3,Interleukin-5 Receptor Alpha Chain,CDw125,Interleukin-5 Receptor alpha Subunit,Interleukin 5 Receptor Type 3,CD125 Antigen,Interleukin 5 Receptor Subunit Alpha,IL-5 Receptor Subunit Alpha,IL-5R-Alpha,IL5R,IL5RA,CD125,IL-5RA,IL-5R Subunit Alpha
최고 연구 개발 단계Approved
영어 이름Interleukin-5 receptor subunit alpha
표적 별명Interleukin 5 Receptor, Alpha,Interleukin-5 Receptor Subunit Alpha,HSIL5R3,Interleukin-5 Receptor Alpha Chain,CDw125,Interleukin-5 Receptor alpha Subunit,Interleukin 5 Receptor Type 3,CD125 Antigen,Interleukin 5 Receptor Subunit Alpha,IL-5 Receptor Subunit Alpha,IL-5R-Alpha,IL5R,IL5RA,CD125,IL-5RA,IL-5R Subunit Alpha
시판 약물 수1
임상 약물 수2
최고 연구 개발 단계Approved

IL-5 R alpha 제품 목록

  • 속성

    Protein (4)

  • 제품 라이브러리

    온라인 (4)

  • Human (3)Mouse (1)

  • 태그

    His Tag (2)Fc Tag (1)Avi Tag & Fc Tag (1)

  • 마커

    Unconjugated (3)Biotin-labeled (1)

IL-5 R alpha분자 배경

Interleukin-5 receptor subunit alpha (IL5RA) is also known as IL-5 receptor subunit alpha, IL-5R subunit alpha and CD125,which is a single-pass type I membrane protein that belongs to the type I cytokine receptor family and type 5 subfamily.IL5R, a heterodimer of an alpha and a beta subunit, is expressed on eosinophils and basophils. IL5RA / CD125 is the receptor for interleukin-5 (IL5) and the alpha chain can bind to IL5. The WSXWS motif of IL5RA appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.The beta subunit of IL5R is common to the IL3, IL5 and GM-CSF receptors.

IL-5 R alpha분자 별명

IL5Ra,CD125

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IL-5 CAR-T Cell Therapy (Zhejiang University)Phase 1 ClinicalZhejiang UniversityHematologic Diseases; Neoplasms
상세
TrabikibartCSL-311Phase 1 ClinicalCsl LtdAsthma
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
BenralizumabKHK-4563; MEDI-563; BIW-8405; BIW-8405-IL-5RApprovedBiowa Inc, Medimmune LlcFasenra, 凡舒卓United StatesAsthmaAstrazeneca Ab2017-11-14Asthma; Asthma, Exercise-Induced; Bronchiectasis; Chronic Urticaria; Dermatitis; Dermatitis, Atopic; Drug Hypersensitivity Syndrome; Eczema; Eosinophilia; Eosinophilic Asthma; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Eosinophilic Granulomatosis With Polyangiitis; Gastroenteritis; Genetic Diseases, Inborn; Granulomatosis with Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases; Leukocyte Disorders; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Sinusitis; Skin Diseases; Skin Diseases, Eczematous; Skin Diseases, Genetic
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호